Definition

A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody QLF3108 targets and binds to the two antigens expressed on T cells and tumor cells respectively. This may activate T cells to kill tumor cells expressing the specific tumor-associated antigen (TAA).